NATURE: Stem-cell regulation

China has ordered a halt to unapproved stem-cell treatments, and says that it will stop accepting new applications for clinical trials using stem-cell products until July. The 10 January announcement by the government's health ministry was viewed as an effort to crack down on a flourishing trade in unproven stem-cell therapies, which are widely offered and loosely regulated in the country.

http://www.nature.com/news/seven-days-6-12-january-2012-1.9779